The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISA 2020 | DISCOVERY: cardiac amyloidosis screening study
Mathew Maurer
• 3 Sep 2020
Mathew Maurer, MD, Columbia University, New York, NY, discusses the results of the DISCOVERY screening study (NCT02252653), which investigated the prevalence of TTR mutations in patients suspected of having cardiac amyloidosis. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
